Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
02/13

DJ Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. $(EW)$ shed 3.64% to $76.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.57% to 6,832.76 and Dow Jones Industrial Average falling 1.34% to 49,451.98.

The stock's fall snapped a two-day winning streak.

Edwards Lifesciences Corp. closed 13.03% short of its 52-week high of $87.89, which the company reached on December 5th.

The stock underperformed when compared to some of its competitors Thursday, as Abbott Laboratories $(ABT)$ fell 1.87% to $111.47, Medtronic PLC $(MDT)$ fell 0.20% to $100.88, and Stryker Corp. $(SYK)$ rose 0.59% to $365.85.

Trading volume (5.4 M) eclipsed its 50-day average volume of 3.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 12, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 12, 2026 16:53 ET (21:53 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10